RecruitingPhase 2NCT04698785

Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients

Studying Bone sarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centre Leon Berard
Principal Investigator
Mehdi BRAHMI
Centre Léon Bérard, Lyon
Intervention
Treatment by regorafenib and best supportive care(drug)
Enrollment
36 enrolled
Eligibility
12 years · All sexes
Timeline
2021 – 2026

Study locations (16)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04698785 on ClinicalTrials.gov

Other trials for Bone sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Bone sarcoma →

← Back to all trials